Screener
Castle Biosciences CSTL Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
Based on trailing twelve months.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
FAQ
- What is Castle Biosciences's gross margin?
- Castle Biosciences (CSTL) reported gross margin of 77.9% in Q1 2026.
- How has Castle Biosciences's gross margin changed year-over-year?
- Castle Biosciences's gross margin decreased by 4.9% year-over-year, from 81.9% to 77.9%.
- What is the long-term trend for Castle Biosciences's gross margin?
- Over 5 years (2020 to 2025), Castle Biosciences's gross margin has grown at a -1.3% compound annual growth rate (CAGR), from 84.5% to 79.4%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Castle Biosciences's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude